Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Reel/Frame: | 042750/0708 | |
| Pages: | 12 |
| | Recorded: | 06/19/2017 | | |
Attorney Dkt #: | P-324-US1 |
Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
Total properties:
1
|
|
Patent #:
|
|
Issue Dt:
|
10/16/2018
|
Application #:
|
15452333
|
Filing Dt:
|
03/07/2017
|
Publication #:
|
|
Pub Dt:
|
09/28/2017
| | | | |
Title:
|
CRYSTALLINE(2S,4R)-5-(5'-CHLORO-2'-FLUORO-[1,1'-BIPHENY]-4-YL)-2-(ETHOXYMETHYL)-4-(3-HYDROXYISOXAZOLE-5-CARBOXAMIDO)-2-METHYLPENTANOIC ACID AND USES THEREOF
|
|
Assignee
|
|
|
901 GATEWAY BLVD |
SOUTH SAN FRANCISCO, CALIFORNIA 94080 |
|
Correspondence name and address
|
|
THERAVANCE BIOPHARMA US, INC.
|
|
901 GATEWAY BLVD
|
|
SOUTH SAN FRANCISCO, CA 94080
|
Search Results as of:
05/24/2024 03:27 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|